An observational study in Colonic Neoplasms, sponsored by Radboud University Medical Center. Completed at 1 site in Netherlands. Per ClinicalTrials.gov, last updated 2025-08-15.
Sponsored by Radboud University Medical Center · Observational
In this study, the investigators aim to assess the influence of a computer-aided detection (CADe) system on the visual gaze patterns of endoscopists in order to further understand the effect of AI during real-time colonoscopy.
1,432 studies on the registry are indexed under Colonic Neoplasms; 357 are open to participants now.
This study's enrollment of 52 is below the median of 280 across 349 observational studies indexed under Colonic Neoplasms.
Browse Colonic Neoplasms studies →Radboud University Medical Center is the lead sponsor of 959 studies on the registry; 134 are open to participants now.
Of its 6 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Adults who are referred for regular care colonoscopy
Exclusion Criteria of patients:
Participating patients who undergo colonoscopy
Physicians performing CADe colonoscopy
Device: eye-tracking glasses
Physicians performing conventional colonoscopy
Device: eye-tracking glasses
endoscopists wear eye-tracking glasses during real-time colonoscopy
Mean gaze time per area of influence
Time frame: End of colonoscopy
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Radboud University Medical Center